4J Therapeutics Inc. — Form D
4J Therapeutics Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-12. The offering totals $10K, of which $10K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-09-12
- Form: D
- Accession: 0001943773-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10K
- Amount sold: $10K
- Investors: 4
- Date of first sale: 2022-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-458589
Issuer
- Name: 4J Therapeutics Inc.
- CIK: 0001943773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 965 CLARK WAY, PALO ALTO, CA, 94304
- Phone: 650-575-4107
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Menashe Elazar | Director | Palo Alto, CA |
| Jeffrey S Glenn | Director | Palo Alto, CA |
| Edward Pham | Director | Palo Alto, CA |
| Nancy Chang | Executive Officer | Houston, TX |
| Menashe Elazar | Executive Officer | Palo Alto, CA |
| Edward Pham | Executive Officer | Palo Alto, CA |
More